Roth Capital Has Negative Estimate for LAKE Q3 Earnings

Lakeland Industries, Inc. (NASDAQ:LAKE) – Investment analysts at Roth Capital reduced their Q3 2026 EPS estimates for Lakeland Industries in a research report issued to clients and investors on Wednesday, September 10th. Roth Capital analyst G. Sweeney now forecasts that the medical instruments supplier will earn $0.18 per share for the quarter, down from their previous forecast of $0.26. The consensus estimate for Lakeland Industries’ current full-year earnings is $0.48 per share. Roth Capital also issued estimates for Lakeland Industries’ Q4 2026 earnings at $0.27 EPS and FY2027 earnings at $1.16 EPS.

A number of other equities analysts have also weighed in on LAKE. Zacks Research raised shares of Lakeland Industries from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 14th. DA Davidson cut their price objective on shares of Lakeland Industries from $23.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday. Finally, Lake Street Capital set a $26.00 price objective on shares of Lakeland Industries and gave the company a “buy” rating in a research report on Tuesday, June 10th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $25.00.

Lakeland Industries Stock Performance

NASDAQ:LAKE opened at $14.24 on Thursday. The firm has a 50 day simple moving average of $14.54 and a 200-day simple moving average of $16.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 3.66 and a quick ratio of 1.51. The firm has a market cap of $135.49 million, a PE ratio of -5.20 and a beta of 1.11. Lakeland Industries has a 1-year low of $12.76 and a 1-year high of $27.28.

Lakeland Industries (NASDAQ:LAKE) last announced its quarterly earnings results on Tuesday, September 9th. The medical instruments supplier reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.40. Lakeland Industries had a negative net margin of 11.22% and a negative return on equity of 3.07%. The company had revenue of $52.50 million for the quarter, compared to the consensus estimate of $54.59 million. Lakeland Industries has set its FY 2026 guidance at EPS.

Lakeland Industries Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 22nd. Investors of record on Friday, August 15th were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $0.12 annualized dividend and a yield of 0.8%. Lakeland Industries’s dividend payout ratio is -4.38%.

Hedge Funds Weigh In On Lakeland Industries

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Private Capital Management LLC increased its position in Lakeland Industries by 0.4% during the fourth quarter. Private Capital Management LLC now owns 1,007,391 shares of the medical instruments supplier’s stock worth $25,739,000 after purchasing an additional 4,092 shares during the last quarter. Royce & Associates LP increased its position in Lakeland Industries by 9.4% during the first quarter. Royce & Associates LP now owns 931,920 shares of the medical instruments supplier’s stock worth $18,927,000 after purchasing an additional 79,940 shares during the last quarter. Pacific Ridge Capital Partners LLC increased its position in Lakeland Industries by 3.8% during the first quarter. Pacific Ridge Capital Partners LLC now owns 297,962 shares of the medical instruments supplier’s stock worth $6,052,000 after purchasing an additional 10,992 shares during the last quarter. First Eagle Investment Management LLC increased its position in Lakeland Industries by 27.3% during the second quarter. First Eagle Investment Management LLC now owns 278,756 shares of the medical instruments supplier’s stock worth $3,794,000 after purchasing an additional 59,803 shares during the last quarter. Finally, Ancora Advisors LLC increased its position in Lakeland Industries by 85.1% during the first quarter. Ancora Advisors LLC now owns 276,688 shares of the medical instruments supplier’s stock worth $5,620,000 after purchasing an additional 127,195 shares during the last quarter. Institutional investors and hedge funds own 71.69% of the company’s stock.

About Lakeland Industries

Lakeland Industries, Inc manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks.